Avail Medsystems, a Palo Alto, Calif.-based medical technology company pioneering telemedicine for the procedure room, raised $100m in Series B funding.
The round was led by D1 Capital Partners, with participation from 8VC and existing investors.
The company intends to use the funds to further expand its business reach.
Led by Daniel Hawkins, CEO, Avail Medsystems has developed Procedural TelemedicineTM technology that digitizes physical presence and enables HIPAA compliant collaboration among a network of healthcare professionals and industry experts. Its Procedural TelemedicineTM System is built to meet the specific needs of physicians and medical experts for remote collaboration during procedures or for clinical education and training.
The system is supported by the Avail Portal, a secure online platform used by a network of medical industry experts and physicians. The Portal allows users to manage schedules, update availability in real-time and collaborate and provides tools to support medical device representatives, particularly those in the field, to run their remote activities and their business, including the ability to manage relationships, track historical utilization and improve time management.